SOHO 4th Italian Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

SOHO 4th Italian Conference

www.sohoitaly.com

Leukemia
Lymphoma
Myeloma
MDS and MPN
CAR-T and Benign Hematology
Event

SOHO Italy 2022: Phase 3 AGILE Study - A Global, Randomized, Double-Blind Study of Ivo + Aza vs. Placebo + Aza in Newly Diagnosed AML With an IDH1 Mutation

By SOHO 4th Italian Conference FEATURING Claudio Cerchione

16 views

November 28, 2022

Comments 0

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

The First Treatment Choice Matters

Feat. A. Ip

Leukemia

SOHO Italy 2022: Targeting Novel Oncogenic Dependencies in AML With …

SOHO 4th Italian Conference

S. Peruzzi

16 views

SOHO Italy 2022: Role of BCOR and DNMT3A Cooperation in the Epigenet…

SOHO 4th Italian Conference

A. Scialdone

25 views

SOHO Italy 2022: How I Treat Blastic Plasmacytoid Dendritic Cell Neo…

SOHO 4th Italian Conference

N. Pemmaraju

19 views

SOHO Italy 2022: Mutation Profiling of AML Patients

SOHO 4th Italian Conference

N. Daver

114 views

SOHO Italy 2022: How I Treat Lymphoblastic Leukemia

SOHO 4th Italian Conference

G. Martinelli

74 views

How I Treat the Older Adult With ALL

Elias Jabbour

210 views

SOHO Italy 2022: Approach to pH+ and pH-Like ALL

SOHO 4th Italian Conference

C. Papayannidis

35 views

SOHO Italy 2022: How I Treat CML at MDACC in 2022

SOHO 4th Italian Conference

E. Jabbour

25 views

SOHO Italy 2022: How I Treat CLL at MDACC

SOHO 4th Italian Conference

A. Ferrajoli

22 views

SOHO Italy 2022: The History of CML - From Nightmare to the Cure

SOHO 4th Italian Conference

G. Saglio

16 views

Non-Intensive Treatment of Older/Unfit Patients With AML

SOHO 4th Italian Conference

T. Kadia

165 views

SOHO Italy 2022: Mutations in AML and the Importance of Molecular Te…

SOHO 4th Italian Conference

G. Martinelli

75 views

SOHO Italy 2022: FLT3 Mutations in AML

SOHO 4th Italian Conference

N. Daver

68 views

SOHO Italy 2022: Why We Should Not Forget Glasdegib in AML

SOHO 4th Italian Conference

A. de la Fuente

119 views

SOHO Italy 2022: Phase 3 AGILE Study - A Global, Randomized, Double-…

SOHO 4th Italian Conference

C. Cerchione

16 views

SOHO Italy 2022: Immune Antibodies and Cellular Therapies in AML

SOHO 4th Italian Conference

N. Daver

14 views

SOHO Italy 2022: Secondary AML - What’s New

SOHO 4th Italian Conference

A. Isidori

94 views

SOHO Italy 2022: Pivekimab Sunirine Triplet With Aza & Ven Shows Bro…

SOHO 4th Italian Conference

N. Daver

15 views

SOHO Italy 2022: New Insights Into AML Biology and Their Concrete an…

SOHO 4th Italian Conference

I. Iacobucci

33 views

SOHO Italy 2022: Pro-Apoptotic Pathways in AML

SOHO 4th Italian Conference

S. Galimberti

8 views

SOHO Italy 2022: New Frontiers in Overcoming Environment-Mediated Dr…

SOHO 4th Italian Conference

C. Cerchione

26 views

SOHO Italy 2022: Present and Future Perspective for Cellular Therapy…

SOHO 4th Italian Conference

A. Rambaldi

65 views

Maintenance in AML: Trials or Reality?

SOHO 4th Italian Conference

M. Gottardi

89 views

SOHO Italy 2022: Next Questions in ALL

SOHO 4th Italian Conference

G. Martinelli

35 views

SOHO Italy 2022: State-of-the-Art and Next Questions in CML Therapy

SOHO 4th Italian Conference

G. Saglio

18 views